Business
DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials
DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials.
About this update from Decision Diagnostics Corp
[{"type":"text","content":"\n \n \n DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials\n \n \nDECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials\n\nUpcoming Challenge Marks New Turning Point in Case Over (J&J's 7,250,105) Patent That Courts Have Since Ruled Should Not Have Been Granted and Cannot Be Used\n\n \n LOS ANGELES, CA--(Marketwired - Jan 14, 2015) - Decision Diagnostics Corp. (OTC PINK: DECN), the manufacturer, quality plan administrator and the exclusive worldwide sales, service and regulatory processes agent for the popular GenStrip™ 50, the FDA cleared Green Glucose Test Strip, specifically designed to work with the market leading Johnson & Johnson's LifeScan Ultra family of glucose testing meters, today announced that on December 19, 2014, the company and its subsidiary Pharma Tech Solutions were notified through a letter addressed to the District Court Northern District of California and authored by the lead counsel for Lifescan Inc. (Johnson & Johnson) and LifeScan Scotland, Ltd. (Lifescan) that the primary expert witness they had engaged to provide two separate expert opinions and declarations on LifeScan's behalf has been revealed to have falsified his credentials. \n Richard Gering of Wilkes-Barre, PA, was presented by Lifescan to the U.S. District Court for the Northern District of California as Dr. Richard Gering, Ph.D., a learned expert in economics, business evaluation and statistical analysis. Mr. Gering's expert declarations have played critical roles in both ascertaining the value of the court bond related to the 2013 preliminary injunction, and in convincing the court not to sanction Lifescan for lost sales associated with its violation of an earlier court order. His testimony, in each instance, was embraced by the court and the trial judge, the Honorable Edward Davila, and formed the basis for those rulings and subsequent actions that have damaged Pharma Tech's viability, legitimacy and commercialization capability from March 2013 through the present.\n Through this letter to the court, Lifescan has now confessed, eighteen months after the given testimony, that their expert Ph.D witness does not now, nor has he ever, held a Ph.D. They further state that he ...